Skip to content
    WLY
    Earnings call· Apr 2026(Q4 FY26)

    JOHN WILEY & SONS Q4 FY26 earnings call WLY

    Jun 16, 2026 Source

    Executive summary

    John Wiley & Sons Q4 FY26 — record margins and cash flow cap a breakout year; Emerald acquisition extends the AI flywheel

    A self-described breakout year validated Wiley's two-engine flywheel: durable research publishing feeding a fast-compounding AI and data-analytics layer, with structural cost takeout converting flat revenue into record margins and cash conversion. The Emerald acquisition deepens scale in social-sciences content for both engines, and management enters FY27 guiding to organic acceleration, continued margin expansion, and a rapid shift of AI revenue from one-time training deals to recurring subscriptions.

    Highlights

    5
    • Record profitability: adjusted EBITDA margin rose 220 bps to 26.2% and adjusted operating margin rose 260 bps to 17.7% — both all-time highs in Wiley's reporting history (Q4 margins: 33.2% EBITDA, +480 bps; 25.3% operating, +520 bps)

    • Free cash flow grew 55% to $195M with conversion stepping up from 32% to 44%

    • Adjusted EPS grew 15% for the full year and 22% in Q4

    • AI revenue grew from $40M to $49M, with the recurring base scaling from ~$1M to $8M and knowledge-feed customers nearly doubling to 19

    • Research revenue grew 4% with article submissions up 25% and output up 11%, well ahead of industry output growth of 6-8%

    Concerns

    4
    • Adjusted revenue was flat to prior year (up 1% including currency) versus the outlook of low single-digit growth, with Learning headwinds the primary difference

    • Learning declined for the full year: academic down 5% and professional down 10% on Amazon inventory practices, softer print, and consumer/corporate spending weakness

    • Research Solutions fell 4% in Q4 on a constant-currency basis on declines in recruitment and marketing services and a soft corporate spending environment

    • Late journal-renewal signings pushed related cash collections from Q4 into Q1 FY27, moderating reported free cash flow

    Guidance & targets

    18
    CategoryTargetConfidence
    FY27 organic revenue growth
    Low to mid-single-digit growth (excludes Emerald)
    high materiality
    High
    FY27 Research revenue growth
    Mid-single-digit growth
    high materiality
    High
    FY27 Emerald revenue contribution
    Approximately $78 million
    medium materiality
    High
    FY27 adjusted EBITDA margin
    26.5% to 27.5%
    high materiality
    High
    FY27 adjusted EPS
    $4.60 to $5.05, including ~$0.10 contribution from Emerald
    high materiality
    High
    FY27 free cash flow
    $205 million
    high materiality
    High
    FY27 capital expenditure
    ~$80 million
    medium materiality
    High
    FY27 total AI revenue
    Above $50 million
    high materiality
    High
    FY27 recurring AI revenue
    2x to 3x the FY26 level (implying ~$16-24M)
    high materiality
    High
    Emerald cost synergies
    $30 million run-rate by year 3, with meaningful/material savings in year 2
    high materiality
    High
    Emerald adjusted EPS accretion
    Modestly accretive in year one
    medium materiality
    High
    Emerald free cash flow accretion
    Accretive in fiscal 2028 (year 2), significant contributor thereafter
    medium materiality
    High
    Emerald return on invested capital
    ROIC exceeding weighted average cost of capital by year 2
    medium materiality
    High
    Q1 FY27 AI licensing year-over-year comparison
    Roughly $25 million unfavorable YoY comparison
    medium materiality
    High
    Q1 FY27 Emerald revenue contribution
    Approximately $14 million (2 months of revenue)
    medium materiality
    High
    FY27 Learning segment trends
    Material improvement — digital growth in academic, frontlist momentum in professional
    medium materiality
    Medium
    FY27 AI training (nonrecurring) revenue
    Material training revenue to continue
    medium materiality
    Medium
    Tech budget product-development mix
    50% to 60% of tech spend on product development
    low materiality
    Medium

    Segment performance

    6
    SegmentRevenueYoYQoQMargin
    Research (total)
    Growth engine of the company with strong recurring revenue and customer retention; Q4 growth driven by recurring revenue models, Gold Open Access, and AI licensing. Q4 margin gains from restructuring savings and efficiency from the end-to-end platform deployment. Variances exclude divested assets and currency.
    Article submissions growth: +25% (FY26)Article output growth: +11% (FY26) vs industry output growth of 6-8%
    +4% FY26Adjusted EBITDA +8% FY26; margin 33.2%, up 110 bps (Q4: adjusted EBITDA +13%, margin +300 bps)
    Research Publishing
    Trajectory now pointing to mid-single-digit growth, driven by market share gains, the Advanced portfolio, society partner wins (ASME), and the research exchange platform.
    Journal and brand expansion: strategy 'paying off' with submissions and output well above industry averages
    +3% FY26; +5% in Q4
    Research Solutions
    Q4 decline from recruitment and marketing services weakness and a soft corporate spending environment. Pivoting from legacy advertising to an audience analytics platform built on modern ad tech, AI-driven product innovation, and verified audiences in a large and growing healthcare advertising market.
    +6% FY26; -4% in Q4 (constant currency)
    Learning (total)
    Margin expansion despite revenue declines reflects disciplined cost management; responses include cost takeout, editorial refocus toward higher-value authors and titles, and acceleration of digital products and inclusive access.
    Q4 adjusted EBITDA -1% (constant currency); margin 46.1%, up 310 bps
    Learning — Academic
    Impacted by a prior-year AI licensing comparison and softer print revenue, partially offset by growth in digital content and courseware.
    -5% FY26; -5% in Q4 (constant currency)
    Learning — Professional
    Reflects market-related challenges around consumer and corporate spending plus the same prior-year AI licensing comparison; Amazon inventory practices weigh on the backlist until lapped in August.
    -10% FY26; -10% in Q4

    Operational metrics

    9
    AI knowledge-feed corporate customers
    19Up from 10 last quarter
    Q4 FY26

    Expansion path is more knowledge-feed collections, more departments, and more use cases; breadth across verticals cited as evidence of the content advantage.

    LLM training customers
    4
    FY26

    Nonrecurring training demand from model developers; management anticipates material training revenue continuing in FY27.

    Nexus content licensing revenue
    $19M
    FY26

    Revenue generated from the Nexus AI licensing partner network, launched this year for other publishers.

    Clinical outcome assessments (COA) revenue
    $11M+68% YoY from $6.5M in FY25; up from $700K in FY21
    FY26

    Wiley holds one of the world's largest COA collections (patient-reported outcomes from clinical trials); cited as the exemplar 'hidden gem' with strong growth expected to continue.

    Advanced journal portfolio revenue
    $70MGrowing at strong double digits
    FY26

    Flagship collection led by Advanced Materials; accelerating as a global top-tier brand across disciplines.

    Corporate unallocated expenses
    Down $23M-15% YoY for the full year; Q4 down $9M, -22% YoY
    FY26

    Central driver of the record margin expansion; AI is becoming a meaningful internal efficiency driver as well as a revenue opportunity.

    Net debt ratio
    1.4xDown from 1.8x a year ago
    FY26 year-end

    Deleveraging driven by earnings growth and divestiture proceeds; management comfortable with pro forma leverage and sees possible opportunities to tighten.

    Total capital returned to shareholders
    $174MUp from $137M in FY25
    FY26

    Combined dividend plus buyback framing; management remains committed to returning excess cash while funding growth engines.

    Dividend increase streak
    32 consecutive years
    FY26

    Per-share amount not stated on the call; dividend raised for the 32nd consecutive year.

    Industry KPIs

    9
    MetricValueDetails
    Total revenueFlat YoY (adjusted); up 1% including currency%
    Net income EPSAdjusted EPS +15% YoY (FY26 adjusted EPS of $4.19)USD
    Adjusted EBITDA26.2% adjusted EBITDA margin%
    CAPEX capital program$65MUSD
    Operating income margin17.7% adjusted operating margin%
    Ai product feature adoption$49M total AI revenueUSD
    M a integration cost synergies$30M targeted cost synergies from the Emerald acquisitionUSD
    Free cash flow operating cash flow$195M free cash flowUSD
    Addressable market capture penetrationEmerald generates only 15% of its revenue from North America vs. that region's 40% of global spend on social-sciences research%

    Product announcements

    5
    ProductTypeDetails
    Nexus content licensing servicelaunch
    Research Exchange platformmilestone
    Registry of mass spectral data (new edition)update
    Gateway platformmilestone
    Three AI growth vectors (database solutions, applied research intelligence, audience monetization)roadmap

    Deals & partnerships

    10
    Emerald PublishingAcquisition$452M all-cash (~$450M cited earlier), roughly 7x adjusted EBITDA on a synergized basis

    Wiley's largest acquisition since 2007. UK-based publisher with nearly 6 decades of heritage: ~500 journals, thousands of data-rich book titles and case studies, and 0.5 million backfile assets; ~$85M revenue, ~92% recurring, 99.6% customer retention, submissions up 28%, mid-single-digit revenue growth, and 37-38% EBITDA margins. Strengthens economics, business, and finance content for research and AI licensing; expands combined portfolio to roughly 2,500 journals.

    VirtusaStrategic technology partnership

    Landmark partnership to transform product innovation and reduce costs; spans all three tech priorities — structural savings, shift of spend to product development, and AI-native innovation.

    IQVIAClinical outcome assessments (COA) partnership

    Deeply strategic relationship in clinical outcome assessments; the companies co-hosted a two-day AI summit with senior leaders from Novo Nordisk, Microsoft, Amazon, Salesforce, the American Heart Association, and Johns Hopkins University on transforming the science-to-patient value chain.

    Open EvidenceContent partnership plus small equity investmentUndisclosed; Wiley took a small equity position5-year agreement

    Research at the point of care; 10 society partners have since been added to the collaboration. Management credits Open Evidence with the 'gold in, gold out' framing of trusted content.

    AnthropicAI partnership — Claude for Life Sciences

    Wiley became the first publisher to partner with Anthropic on Claude for Life Sciences (transcript renders the name as 'Amthropic' — ASR error).

    Amazon Web Services (AWS)Life Sciences partnership

    First of the year's sequence of healthcare-AI ecosystem partnerships.

    MicrosoftProduct integration partnership

    Integrates trusted Wiley medical research directly into Microsoft Dragon Copilot, the AI-powered clinical assistant.

    American Society of Mechanical Engineers (ASME)Society publishing partnership

    ASME had self-published for nearly 150 years before choosing Wiley; cited as evidence of scale, reputation, and partnering capability driving society wins.

    American Cancer SocietyPublishing partnership renewalPartnership now in its 30th year

    Highlighted as an example of 'partner of choice' within the 600-plus society partner ecosystem.

    Liverpool University PressCustomer contract — Research Exchange platform

    Liverpool will manage and modernize its academic publishing workflows and scale its journals on Wiley's platform; management sees a meaningful market for migrating additional smaller publishers.

    Risks & headwinds

    4
    Retail channel disruption in Learning from Amazon's inventory practicesThrough roughly Q1-Q2 FY27 (lapping in August)

    Began August 2025; weighs on backlist year-over-year comparisons until lapped in August 2026; contributed to academic and professional revenue declines

    Mitigation: Expected stabilization of Amazon's practices, stronger frontlist productivity, acceleration of digital products and Inclusive Access, and cost takeout

    Soft consumer and corporate spending pressuring professional publishing, assessments, and Research SolutionsOngoing into FY27

    Drove the professional decline and the Q4 constant-currency drop in Research Solutions (recruitment and marketing services)

    Mitigation: Pivot from legacy advertising to an audience analytics platform on modern ad tech; new products and capabilities in assessments; editorial refocus toward higher-value authors and titles

    Variability of nonrecurring AI (LLM training) revenueFY27

    Explicitly unquantified — 'a little bit of uncertainty when you're dealing with the nonrecurring revenue'

    Mitigation: Material shift toward recurring AI revenue (knowledge feeds, subscriptions) and repeat training customers

    Late journal-renewal signings shifting cash collections from Q4 into Q1Recaptured in Q1 FY27

    Not quantified in dollars; moderated FY26 free cash flow; management called it 'not overly material' and not a trend

    Mitigation: Deals closed within the year with only payment timing affected; renewal season characterized as strong despite research-funding uncertainty at the start of FY26

    Q&A highlights

    8

    Crystallize the FY27 outlook for LLM training monetization, third-party data/content partnerships, and recurring revenue — and whether the $50M+ is a baseline with upside.

    Craig confirmed confidence in above $50M for FY27 with a material shift from nonrecurring training to recurring revenue at 2x-3x the FY26 level, while flagging some uncertainty in the nonrecurring piece; some vectors will ramp in FY27 while others are investment areas, with more detail at the FY27 Investor Day. Matt added that the three vectors are the future growth engines beyond FY27, each with significant addressable markets.

    There's a little bit of uncertainty when you're dealing with the nonrecurring revenue, but we're really pleased with the momentum we see in the areas we're investing in the areas of the recurring revenue that are ramping up right now.

    asked by Dan Moore (CJS Securities) · answered by Craig Albright (EVP & CFO)

    5 min read7 chapters

    Detailed Narrative

    01

    The Two-Engine Flywheel: Research Feeding AI, AI Accelerating Research

    Management framed Wiley around two reinforcing growth engines: research publishing (the durable, mid-single-digit foundation built on scale and society relationships) and AI/data analytics (the emerging engine layering research intelligence services over the same proprietary content). The moat is depth in AI-relevant domains: leading positions in 150-plus disease areas in life sciences and healthcare, over 100 chemistry areas including one of the world's most comprehensive spectral database collections, 50-plus areas each in engineering and material science, 48 agriculture and food-science topics, and — with Emerald — top-1-or-2 positions in key areas of economics, business, and finance. Beyond articles, Wiley holds structured metadata, validated research protocols, peer-review signals, citation networks, and author/institutional relationships. More than 14,000 new peer-reviewed articles are published industry-wide every day, and management stressed a capital-light, AI-first, platform-agnostic partnering model that avoids defending legacy platforms while creating network effects.

    02

    Research Momentum and Society Partnerships

    Research is taking share, with large-scale, high-quality publishers gaining at the industry's expense. The society ecosystem of 600-plus partners delivered a landmark signing of the American Society of Mechanical Engineers — which had self-published for nearly 150 years — and a renewal of the 30-year American Cancer Society partnership. The flagship Advanced journal collection was praised by an industry newsletter as 'quietly building an enviable portfolio.' The research exchange platform landed its first external publisher client in Liverpool University Press, which will use it to modernize workflows and scale its journals; management sees a meaningful market in migrating additional smaller publishers facing the same pressures onto the platform, and a full launch is planned for fiscal 2027.

    03

    Emerald: Largest Acquisition Since 2007

    The all-cash Emerald Publishing acquisition is a scale play in high-margin, recurring research publishing and a content play for AI. It makes Wiley a powerhouse in the social sciences — economics, business, finance and related fields — expanding the combined portfolio to roughly 2,500 journals with leading positions across all key publishing areas. Prospective AI customers for the acquired content include financial services firms, consultancies, and business schools. Management emphasized integration confidence: Emerald's operating model (journal publishing, content licensing, recurring institutional revenue) mirrors Wiley's own, the integration draws on a proven playbook, and the research exchange platform is purpose-built to onboard journal assets quickly. Emerald is described as UK-based, mission-driven, and a strong cultural fit with performance-aligned incentives.

    04

    AI and Data Analytics: From Content Access to Intelligence

    Management laid out three organic AI growth vectors, each with its own path and large addressable markets: database solutions (in-demand proprietary data sets like clinical outcome assessments), applied research intelligence (a synthesis-first platform embedding Wiley content in corporate R&D workflows, moving up the value chain), and audience monetization (scaling data assets and reach into an analytics and ad-tech platform), with a fuller readout promised at a fiscal 2027 Investor Day. The healthcare AI ecosystem built through the year: the AWS Life Sciences partnership at the start of FY26, becoming the first publisher on Anthropic's Claude for Life Sciences in July, the IQVIA clinical outcome assessment partnership in November, and March agreements with Open Evidence and Microsoft. Wiley and IQVIA co-hosted a two-day AI summit with senior leaders from Novo Nordisk, Microsoft, Amazon, Salesforce, the American Heart Association, and Johns Hopkins University. Management is also monitoring IP copyright court decisions expected in the coming months, which it believes will further validate the value of its content.

    05

    Cost Discipline and Tech Transformation

    Three workstreams drive the cost agenda: tech transformation (the largest multiyear savings driver — consolidating facilities, retiring technical debt, and the Virtusa partnership), corporate cost structure (streamlining shared services across finance, operations, HR, and marketing), and AI productivity (initiatives in legal, marketing, and content operations, plus a new AI Center of Excellence). Over two years, adjusted EBITDA margin and adjusted operating margin have expanded 340 and 560 basis points respectively, share repurchases have more than doubled, and return on invested capital is described as substantially higher. Virtusa spans all three tech priorities — operational efficiencies, enterprise modernization, and freeing capital for product innovation.

    06

    Learning: Stabilization Actions and Improvement Drivers

    Learning faced market-related challenges all year — Amazon's inventory practices (which began in August 2025 and will weigh on year-over-year comparisons until lapped this August), softer print, and consumer/corporate spending headwinds in professional publishing and assessments. Management responded by taking out costs, refocusing editorial toward higher-value authors and titles, and accelerating the shift to digital products and inclusive access. Scientific and technical book programs are seen as data-dense content with a meaningful AI monetization opportunity that the company is actively pursuing. Q4 academic results were also depressed by a prior-year AI licensing comparison, partially offset by growth in digital content and courseware.

    07

    Leadership, Capital Allocation, and Outlook Framing

    Jessica Kowalski joined as General Manager of Research from Microsoft, where she held full P&L accountability for a global AI, data, and cloud services business, after leading data and analytics partnerships at AWS and spending 11 years in senior roles at Relic (as transcribed) helping elevate it from publisher to information-analytics company; she succeeds the departing Jay Flin (as transcribed). She joins CFO Craig Albright and Rafal (as transcribed), Chief AI and Data Analytics Officer, among FY26 leadership additions. Capital allocation follows four priorities: organic investment first, M&A (Emerald), portfolio optimization (ongoing divestiture evaluation for fit to growth and margin profile), and shareholder returns under a 'dividend forward' policy with opportunistic buybacks — management believes the shares are undervalued. Wiley was named one of the world's most impactful companies by Time Magazine, will be a key sponsor at the UN's AI for Good Summit, and enters its 220th year in 2027.

    AI-generated summary of the company’s earnings call. Not investment advice.